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ABSTRACT   
The increasing demand for early detection of diseases drives the efforts to develop more and more sensitive techniques to 
detect biomarkers in extremely low concentrations. Electromagnetic modes at the surface of one dimensional photonic 
crystals, usually called Bloch surface waves, were demonstrated to enhance the resolution and constitute an attractive 
alternative to surface plasmon polariton optical biosensors. We report on the development of Bloch surface wave biochips 
operating in both label-free and fluorescence modes and demonstrate their use in ovalbumin recognition assays. 
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1. INTRODUCTION  
Recently, Bloch surface waves (BSW) propagating at the surface of truncated one dimensional photonic crystals1,2 (1D-
PC) have been suggested for label-free biosensors based on optical configurations similar to those used in surface plasmon 
resonance (SPR)3,4, including angularly resolved detection modes. BSW biosensors feature very low angular resonance 
widths compared to that of SPR, due to the low losses in the dielectric stacks5. Furthermore, the optimization of the 1D-
PC stack, in terms of geometry and materials, offers the possibility to improve the label-free operation, by tuning the 
resonance position and width6,7. 
When targeting analytes at low concentrations, label-free biosensing may suffer from less-than-ideal suppression or 
referencing of unspecific effects and yield a non-adequate limit of detection (LoD). Coupling, in a single instrument, the 
label-free operation to a complementary detection system relying on the detection of fluorescent labels leads to a 
multimodal analysis and can decrease the LoD. The strong field localization and enhancement at the 1D-PC surface, and 
the absence of quenching, favor utilizing BSW coupled fluorescence emission8,9. In such a coupled configuration, the BSW 
properties are exploited in two ways. First, the BSW angular resonance position is tracked as a label-free signal. Second, 
the BSW coupled emission yields a specific fluorescence detection whenever a labelling step is performed.  
We report on the development and results of a combined label-free and fluorescence biosensing platform utilizing 
disposable biochips. As described in our previous works10,11, a new optical system has been designed and fabricated, 
combining SPR-like angularly resolved resonance and the detection of fluorescent labels. All analysis can be performed 
in a parallel manner for multiple spots that are arranged as a one-dimensional array inside a microfluidic channel. In order 
to enable for later on disposable use, injection molded polymer substrates have been prepared and coated with low loss 
1D-PC. Here we demonstrate the use of this multimode platform in ovalbumin recognition assays. 
2. BSW BIOCHIPS 
BSW are localized at the interface between a finite 1D-PC and an external medium by Bragg reflection and total internal 
reflection (TIR) on the two sides of the interface, respectively4. Like in SPR, the excitation of a BSW at a given wavelength 
  
 
 
 
 
0 can be obtained by a prism coupler in the Kretschmann-Raether configuration12. The BSW excitation appears as a dip 
in the angular reflectance spectrum, whose position is very sensitive to refractive index perturbations at the interface and 
this attractive property can be used for bio-sensing13. 
The fabrication of the 1D-PC was carried out by plasma ion assisted evaporation of dielectric materials (PIAD) under high 
vacuum conditions. PIAD enables the fabrication of dielectric multilayers with low absorption losses and the possibility 
to deposit on plastic substrates14. 
As substrates for the 1D-PC deposition we used purposely developed and manufactured injection molded polymer chips 
made out of TOPAS®,11. These comprise a prism shaped cross section in order to excite the BSW in Kretschmann 
configuration. Additionally, a two-component flow cell has been molded. It consists of a hard polymer cover that can be 
clicked by hand onto the chip. Inside this cover an elastomer defines a straight micro channel of 800 µm x 100 µm cross 
section as well as perpendicularly aligned fluid connectors. 
We used SiO2, Ta2O5 and TiO2 as dielectric materials for the 1D-PC deposition by PIAD. The complex refractive indices 
of such dielectric materials were determined either by reflection/transmission spectroscopy on single supported thin films 
or by ellipsometry on test multilayers sustaining BSW to be nSiO2 = 1.474 + i 5×10–6, nTa2O5 = 2.160 + i 5×10−5, and nTiO2 
= 2.28 + i 1.8×10-3 at the chosen wavelength of operation λ0 = 670 nm15. Using such values enables one to optimize the 
stacks for operation in water environment according to the considerations published elsewhere7. The final structure of the 
stack is shown in Figure 1(a), where the transverse intensity distribution for the BSW at 0 is also shown. In this stack, a 
20 nm thin TiO2 layer is combined with a periodic SiO2 / Ta2O5 stack of 275 nm and 120 nm thicknesses, respectively. In 
order to work with silane-based surface functionalization protocols, the stack is covered with a 20 nm thin SiO2 layer. 
Figure 1(b) illustrates the dispersion of the resonance in the wavelength-angle plane. Two surface modes exhibiting 
different polarization are apparent. The TE resonance has been optimized for label-free sensing, but the stack design 
supports a rather wide and shallow TM mode at lower angles (wavelengths). Here only the TE mode is utilized for label-
free operation, whereas both TE and TM modes contribute to the fluorescence operation.  
 
Figure 1. (a) Sketch of the 1D-PC operating in water environment with TE intensity distribution at 0. The substrate is made of 
TOPAS® polymer. (b) Grey scale plot of angularly and spectrally resolved reflectivity of the stack when illuminated from the 
substrate. (c) Emission pattern of DyLight650 dye molecules located on top of the thin film stack and plotted in grey scale 
representation. The labels “TE” and “TM” indicate the polarization of the resonances and “TIR” the dispersion of the total 
internal reflection edge. Along the vertical and horizontal axes the emission spectra of DyLight 650 either in water solution or 
on top of the biochip (in water) are superimposed, respectively.  
Fluorescence emission by randomly oriented dye labels located on top of the 1D-PC is simulated rigorously by means of 
a transfer-matrix algorithm16 frequently applied for the modelling of Organic LED17. In Figure 1(c) we show the results 
when the emission spectrum of the DyLight650 dye (Abcam, UK) is assumed18. The fluorescence emission is coupled 
preferentially into the surface modes, leading to a resonant enhancement8 and to the possibility to collect it in a narrow 
angular range. Fluorescence is emitted according to the dispersion of the BSW resonance, therefore each wavelength 
component is emitted at a slightly different angle as defined by the 1D-PC dispersion. 
 
3. OPTICAL CONFIGURATION OF THE DETECTION PLATFORM 
In Figure 2 we show a simplified scheme of the optical system for BSW-based biosensing. For label-free operation (Figure 
2a), a collimated light beam (B) is focused by a cylindrical lens (C1) into the biochip. The prismatic shape of the TOPAS® 
  
 
 
 
 
substrate permits to operate above the critical angle for TIR at the biochip/external medium interface. A laser diode at 0 
is used to achieve proper resolution of the narrow angular BSW resonances. The detection optical system features an 
extended CCD detector (Apogee Ascent equipped with Sony ICX814 CCD chip) to obtain 3388 (angular axes) and 2712 
(position axes) pixels readout. 
The cylindrical Fourier lens (F) permits to image the angular reflectance spectrum on the CCD detector. The angular field 
of view is determined by the cylindrical Fourier lens to be approximately 2.9 deg. Full discretization of the CCD chip (no 
binning) is exploited in order to achieve proper sampling of the resonance. 
The cylindrical focusing approach creates an illuminated line along the direction x on the surface. Several measurement 
spots can be arranged in a row along the illuminated line. Parallel readout of the spots is achieved by using a cylindrical 
detection optical system that consists of objective (C2) and tube lens (C3) systems in order to image the direction x onto 
one coordinate of a CCD detector. The lateral field of view (coordinate x in Figure 2) is approximately 6 mm; 8 pixels 
binning is applied, complying to the spatial resolution of lateral imaging. The design of the optical detection system ensures 
that the same angular range is observed for all spots along the illuminated region on the sensor surface. 
 
Figure 2. Simplified view of the BSW-based optical system in label-free (a) and fluorescence (b) modes (from Ref.11). In the 
label-free mode (a), a collimated beam (B) is focused by means of a cylindrical lens (C1) into the chip to create an illuminated 
line. A Fourier lens (F) images the angular spectrum of light reflected at the sensor surface onto the CCD detector. Cylindrical 
objective (C2) and tube lens systems (C3) image the lateral coordinate onto one axis of the CCD detector. An additional 
cylindrical lens (Z) is introduced for fluorescence detection (b) to increase the angular detection range. 
The fluorescence operation is based on properly selected dye labels which emit around 0, after excitation at a lower 
wavelengthSuitable dyes are: DyLight650 from Abcam, Alexa 647 from Thermo-Fisher, and Cy5. Dyes detection follows 
the approach described recently9 and is based on exc=635 nm illumination. Spatial imaging and binning are identical to 
the label-free case. However, Figure 1c illustrates that the angular range used for the label-free operation (2.9 deg) would 
be too small to detect the full angular emission spectrum for both TE and TM polarizations. Therefore, an additional 
cylindrical lens (Z) in Figure 2(b) is introduced into the light path in order to increase the angular field of view. The limited 
angular resolution associated with this approach is acceptable, and consequently angular binning of 8 pixels is utilized in 
fluorescence detection mode. 
  
 
 
 
 
Filter elements for selecting a certain polarization and/or spectral range are arranged in-between the cylindrical objective 
(C2) and tube lens (C3) systems. The spectral fluorescence emission filter (Chroma 685/70) is fixed in the detection optics 
because the label-free operation wavelength 0 is well within the fluorescence emission band and transmits such element. 
4. ASSAY FOR OVALBUMIN DETECTION 
In order to test the performance of the biosensing platform we developed, we carried out assays for the detection of 
ovalbumin (OVA) at several different concentrations in D-PBS 1X buffer. Figure 3 depicts the steps of the protocol we 
used in this detection assay. We briefly describe the protocol before discussing each step in detail in the following. 
The protocol starts with a preparation phase beginning from a bare BSW chip constituted by a 1D-PC with top SiO2 layer 
deposited on a TOPAS® substrate. In the test experiments reported here, each biochip surface is divided into two areas 
defined as signal and reference regions. In the two regions we immobilize either the specific antibody anti-ovalbumin (a-
OVA) or a non-specific antibody anti-Angiopoietin 2 (a-Ang2), respectively. These two regions are illuminated 
simultaneously by the optical system and permit subtracting parasitic contributions taking place during the assay. After 
preparation, the biochip is topped with the hard polymer cover and its elastomer contact element, defining the straight 
micro channel passing over the two measurement regions. Then the biochip is mounted in the optical system (clicked in) 
and is used for the label-free and fluorescence assays.    
 
 
Figure 3 – Protocol used for the ovalbumin detection assays. Each BSW chip is divided into two areas defined as signal and 
reference spots. Capture antibodies and non-specific antibodies are conjugated onto the chip surfaces (signal spot and reference 
spot, respectively) by silane-based conjugation chemistry. The presence of ovalbumin can be detected based on label-free sensing. 
Subsequent addition of detection antibodies and fluorescent dyes enables detection at fluorescence mode.   
 
4.1 Biochip preparation 
In order to obtain a clean silica surface of the biochips, the bare 1D-PC surfaces were exposed to a piranha solution (3:1 
mixture of sulfuric acid and 30% hydrogen peroxide) for 10 minutes. Subsequently, the substrates were carefully rinsed 
with de-ionized (DI) water and dried under a stream of nitrogen gas. The cleaned biochips were then immersed into a 2% 
(v/v) solution of APTES ((3-Aminopropyl)triethoxysilane from Sigma-Aldrich) in ethanol/water (95:5 v/v) mixture at 
ambient temperature for 1 h. Afterwards the chips were removed from the solution, sonicated (~30 s), rinsed with ethanol, 
and dried on a hot plate at 80 °C for 1 h. 
  
 
 
 
 
The specific (a-OVA) and non-specific (a-Ang2) antibodies immobilization starts with the coupling of the silane with 1% 
(v/v) glutaraldehyde (GAH) (Sigma-Aldrich) solution in 100 mM sodium bicarbonate buffer (pH 8.5) in the presence of 
0.1 mM NaCNBH3 (sodium cyanoborohydride, Sigma-Aldrich) for 1 h at room temperature. A further sonication in DI 
water was performed prior to thoroughly rinsing the biochips with DI water. A 0.5 mg/ml (40 l) solution of Protein G 
(PtG) (Thermo Scientific) in sodium bicarbonate buffer was dropped on the sensing area, allowed to react for 1 h at room 
temperature, and then removed by washing with D-PBS 1X. The role of PtG is to properly orient the capture antibodies 
and maximize their recognition efficiency. 
After PtG immobilization we proceeded with the definition of the two sensitive regions. These are separated from each 
other by a permanent marker that is used to draw a line in the middle of the biochip channel, that works as a hydrophobic 
barrier for the antibodies solutions during immobilization. We incubated overnight at 4 °C a-Ova (8 µM, 20 µl) in one 
region of the biochip and a non-specific anti-Angiopoietin 2 (R&D Systems) antibody (a-Ang2) (20 µg/ml, 20 µl) in the 
other region, as a negative control. After a washing step with D-PBS 1X the chip was blocked with BSA (10 mg/ml) for 1 
h at room temperature.  
Immediately before use the surface of the biochips was treated with a regeneration solution made of 100 mM glycine 
(Sigma-Aldrich) and HCl with a pH of 2.0 at ambient temperature. This step improves the recovery of surface reactivity 
after the blocking step in BSA, because any adlayers should be removed. All reagents such as ethanol (99.8%), sulfuric 
acid (95%), 30% hydrogen peroxide solution and phosphate buffer saline (D-PBS 1X, pH 7.4) were obtained from Sigma-
Aldrich and were used as it is. 
Finally the biochip is rinsed with D-PBS 1X buffer again, is topped with the microfluidic element and is mounted mounted 
via a temperature controlled support in the optical system. 
4.2 Label-Free assay 
Once the biochip is mounted on the optical system the microfluidic channel is filled with D-PBS 1X and the position of 
the BSW resonance is tracked as a function of time in all positions along the illuminated strip. All injection and 
recirculation steps are performed at a flow rate of 5.5 l/s. After acquiring the signal for a convenient time interval to be 
used as a baseline, we started injecting the OVA solutions in D-PBS 1X according to the following procedure: 1) Washing 
with 500 µl D-PBS 1X; 2) OVA sample injection (60 µl); 3) recirculation of the solution by backward/forward pumping 
(50 cycles of 30 µl); 4) Washing with 1000 µl D-PBS 1X; 5) Regeneration with 100mM Glycine-HCl pH 2.0. We repeated 
the procedure for the following OVA concentrations in D-PBS 1X: 0.7 nM, 2.1 nM, 6.3 nM, 18.9 nM, 56.7 nM, 170 nM 
and 467 nM. Such molar concentrations correspond to the following weight concentrations: 0.03 g/ml, 0.09 g/ml, 
0.27 g/ml, 0.81 g/ml, 2.43 g/ml, 7.29 g/ml and 20 g/ml. 
Figure 4 presents the kinetic curves obtained after injecting OVA at three concentrations (0.03 g/ml, 0.27 g/ml, 
2.43 g/ml). The angular position of the BSW resonance measured in CCD pixel (1 pixel = 0.856 mdeg) is plotted as a 
function of time. The kinetic signals measured in two different spots in the a-OVA region of the biochip are shown. In 
both cases the reference signals measured in two separate spots of the a-Ang2 negative control region on the biochip were 
subtracted. We observe that the signal response increases with the injected OVA concentrations. At the end of the OVA 
recirculation and after washing with D-PBS 1X the signal decreases to a stable residual value that is related to the amount 
of OVA captured at the surface.  
In Figure 5, we show the residual BSW resonance shift (in CCD pixels) after OVA injection and washing with buffer, for 
two different OVA concentrations (7.29 g/ml and 20 g/ml). The surface of the biochip was probed by the illumination 
beam in 108 spots. The spots from 0 to 50 are in the a-OVA region, those from 51 to 64 are in the hydrophobic marker 
region, and those from 65 to 107 are in the a-Ang2 negative reference region. The residual shift is homogeneous in the two 
regions and the average value is larger in the signal region with respect to the negative reference. 
The signals measured during the assays in all spots, and similar to those shown in Figure 4 for just two spots, were averaged 
over several spots in the signal (PtG/a-OVA) and in the reference region (PtG/a-Ang2). The number of spots in the 
averaging varies between 14 and 40, being around 30 for the majority of the data sets. Then the average signals obtained 
for the signal and reference regions were subtracted to compensate for any drift. 
 
  
 
 
 
 
 
 
Figure 4 – Binding kinetic curves for 3 different Ova concentrations (0.03 g/ml, 0.27 g/ml, 2.43 g/ml). For each 
concentration the signals measured in two spots in the a-OVA region of the chip are shown (light and dark grey curves). 
 
 
 
Figure 5 – BSW resonance residual shift after incubating OVA at two different concentrations, 7.29 g/ml and 20 g/ml. The 
signals were measured in 108 spots along the illuminated surface of the biochip. The right region (0,50) is with PtG/a-OVA 
and the left region (65,107) is the reference with PtG/a-Ang2. The central region corresponds to the hydrophobic markers 
region were the BSW resonance is absent. 
 
In all the assays carried out with the a-OVA/OVA system we observed that the regeneration procedure does not remove 
proteins/complexes from the biochip surface. Therefore, it is likely that the residual signals found in Figure 4 after D-PBS 
1X washing are additive. In Figure 6 we show a plot the cumulated residual shift of the BSW resonance as a function of 
the concentration of the respective OVA solution. The green dots (light grey in black and white) correspond to the 
cumulated residual shift after washing with D-PBS 1X and the blue dots (dark grey in black and white) were calculated 
  
 
 
 
 
summing the resonance shift at the end of the recirculation for the given concentration to the residual shift for the 
concentration injected before. 
 
Figure 6 – Cumulated label-free signals extracted from measurements for all OVA concentrations, similar to those shown in 
Figure 4. The green dots (light grey) correspond to the cumulated residual shift after washing with PBS. The blue dots (dark 
grey) were calculated summing the mean maximum shift for the given concentration to the residual shifts for the concentrations 
injected before. 
 
In Figure 6, the cumulated label-free signal at the end of the incubation of OVA concentrations (blue/dark grey dots) can 
be fitted to the model d = d0 + dmax / (1 + (KAC)-1) (blue/light grey curve), with values for the parameters reported in Table 
1. The dmax and KA get the same values (within the error) as those obtained by fitting the concentration dependence of the 
cumulative residual shift (green/light grey dots) to the model d = dmax / (1 + (KAC)-1) (green/light grey curve). 
The blue (dark grey) fitting curve in Figure 6 confirms that the binding process follows the expected behaviour for a 
Langmuir isotherm19. However the presence of a large non-zero d0 distorts the curve in the limit of small concentrations, 
indicating the presence of a parasitic signal due to non-specific binding at the biochip surface. Probably such behaviour is 
due to an insufficient blocking of the biochip surface that adsorbs OVA biomolecules not-specifically in open binding 
sites. This result suggests that care should be taken to block the biochip surface with the aim to reduce d0 as much as 
possible, ideally down to zero. 
 
Table 1. - Values of the parameters used to fit the concentration dependence of the cumulated label-free for the Ova assay. 
Parameter Value 
dmax(pix) 32.0 ± 1.9 
KA(M-1) (4.24 ± 0.98)  107 
d0 (pix) 3.34 ± 0.71 
 
From the analysis of the data reported in Figure 6 we can determine the limit of detection of the platform when operated 
in the label-free mode (LoDLF) for the a-OVA/OVA system. Once d0 is determined, we can assert that a signal can be 
detected if it differs from d0 by more than twice the standard deviation () of its associate measurement error. From the 
equality dmax / (1 + (KAC)-1) = 2, we then find LoDLF = 1.45 nM, corresponding to 60 ng/ml. 
 
4.3 Fluorescence assay 
From the analysis of the label-free experiments reported above it is clear that, for low OVA concentrations, the signals are 
affected by large errors due to not perfect compensation of parasitic effects (non-specific binding, local temperature and 
pressure effects, functionalization and immobilization inhomogeneities). The signals are immersed in a relatively large 
noise that does not permit to infer any information on OVA binding events. This limits the LoDLF as shown above. In this 
  
 
 
 
 
respect the complementary fluorescence assay permits to decrease of the limit of detection and discloses information on 
the OVA binding process. 
As an example in Figure 7 (left) we show the result of a label-free assay carried out at an OVA concentration of 30 ng/ml. 
With respect to the measurements reported in the Section 4.2 here in the reference spot we immobilized anti-Human Serum 
Albumin (a-HSA) as a non-specific antibody (8 M for 1 hour at ambient temperature). The curve is the difference between 
the averaged BSW minima positions in the signal and reference regions (22 and 42 spots of the a-OVA and a-HSA regions, 
respectively). 
Starting from t=0 min, the assay was carried out according to the following protocol: 1) OVA injection (100 µl at 30 
ng/ml); 2) Backward/forward recirculation (50 cycles of 25 µl); 3) Washing twice with 500 µl PBS; 4) Background 
Fluorescence measurement (integration time 1 ms); 5) Washing with 500 µl PBS; 6) Biotin-Labelled a-OVA* injection 
(100 µl at 10 µg/ml); 7) Backward/forward recirculation (50 cycles of 25 µl); 8) Washing twice with 500 µl PBS; 9) 
Labelled neutravidin (Dylight-650) injection (100 µl at 10 µg/ml); 10) Backward/forward recirculation (50 cycles of 25 
µl); 11) Washing with 500 µl PBS; 12) Fluorescence Measurement (integration time 1 ms). All injections were carried out 
at a flow speed of 5.5 µl/s. 
In Figure 7 (left) the time origin is set to the moment of injection of 100 l of OVA solution. The various injections take 
place during the time intervals: (0, 9 min) OVA; (18, 27 min) biotinylated detection a-OVA*; (32, 41 min) Dylight650 
labelled neutravidin. Fluorescence emission was measured in two time intervals: (12, 16 min) before labelling, (46, 50 
min) after labelling with Dylight-650. 
 
  
Figure 7 – (left) Kinetics of the difference of the averaged BSW resonance angles in the signal and reference regions (22 spots 
of the a-Ova region and 42 spots of the a-HSA region) upon injection of Ova at 30 ng/ml, biotinylated detection a-Ova at 
10 g/ml, and Dylight-650 labelled neutravidin at 10 g/ml. (right) Angular distribution of the background subtracted 
fluorescence emission in the reference (a-HSA) region (green) and in the signal (a-Ova) region (red). 
 
As it can be seen the difference signal goes back to the starting level after injection of OVA at 30 ng/ml and subsequent 
washing with D-PBS 1X (t12 min). Such result confirms that the concentration 30 ng/ml is below the limit of detection 
of the label-free operation mode (for the used surface chemistry and protein immobilization procedures). After performing 
the second part of the assay, t(17, 46 min), the label-free signal is enhanced due to the mass loading effect when the 
detection antibody and the neutravidin bind to the OVA captured at the surface. One can observe a differential shift of the 
BSW resonances during the incubation of the species and a residual shift of about 1.5 pixel. However, the uncertainty of 
the measurement is still too large to claim label-free detection. 
 
In Figure 7 (right) we show the result of the fluorescence measurement for the same OVA assay at 30 ng/ml. The curves 
represent the angular distributions of the background subtracted fluorescence emission in the reference (a-HSA) region 
(green) and in the signal (a-OVA) region (red). The curves were obtained by averaging 20 spots in either the reference or 
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in the signal region. As it can be seen the fluorescence intensity in the signal region is well distinguished from the intensity 
in the reference region. 
If we assume that for very low concentrations the density of bound OVA biomolecules, and therefore the fluorescence 
signal scales linearly, then we can estimate the limit of detection of the platform in the fluorescence mode: 
𝐿𝑜𝐷𝐹𝐿𝑈𝑂 = 30𝑛𝑔/𝑚𝑙 ∙
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝐶𝑜𝑢𝑛𝑡𝑠 (𝐴𝑛𝑡𝑖 − 𝐻𝑆𝐴)
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝐶𝑜𝑢𝑛𝑡𝑠 (𝐴𝑛𝑡𝑖 − 𝑂𝑉𝐴)
|
30𝑛𝑔/𝑚𝑙
 
 
Extracting data from Figure 7 (right) one gets LoDFLUO= 3.80.5ng/ml corresponding to 0.08 0.01 nM. Such results 
demonstrate that the implementation of the fluorescence detection, not available in the SPR case, can lead to an 
improvement of the limit od detection, that is at least 10 times smaller than what found in the label-free mode. 
5. CONCLUSIONS 
The present work describes an approach based on BSW to combine label-free and fluorescent labels detection in a single 
biosensing platform. 
Low loss one dimensional photonic crystals featuring narrow surface wave resonances have been designed and fabricated 
on injection molded chips. A sandwich assay that detects ovalbumin has been successfully demonstrated. The tracking of 
the angular resonance position yields a label-free detection with LoDLF = 60 ng/ml. This result is supported by the clear 
difference of fluorescence intensities obtained on measurement and reference spots, indicating a much lower limit of 
detection LoDFLUO = 3.8 ng/ml. 
As a whole, successful combination of label-free and fluorescence modes in one optical detection system is achieved. 
Notably, the combination of angular and wavelength resolution in fluorescence mode yields new parameters for read-out 
that opens up new possibilities for designing different assays. The complete technological platform constituted by the 
instrument and the biochips is available for large scale production thus making the chip approach a valid candidate for 
disposable biosensor application. 
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